Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
There are unexplained links between human exposure to aluminium and the incidence, progression and aetiology of Alzheimer's disease. The null hypothesis which underlies any link is that there would be no Alzheimer's disease in the effective absence of a body burden of aluminium. To test this the latter would have to be reduced to and retained at a level that was commensurate with an Alzheimer's disease-free population. In the absence of recent human interference in the biogeochemical cycle of aluminium the reaction of silicic acid with aluminium has acted as a geochemical control of the biological availability of aluminium. This same mechanism might now be applied to both the removal of aluminium from the body and the reduced entry of aluminium into the body while ensuring that essential metals, such as iron, are unaffected. Based upon the premise that urinary aluminium is the best non-invasive estimate of body burden of aluminium patients with Alzheimer's disease were asked to drink 1.5 L of a silicic acid-rich mineral water each day for five days and, by comparison of their urinary excretion of aluminium pre-and post this simple procedure, the influence upon their body burden of aluminium was determined. Drinking the mineral water increased significantly (P<0.001) their urinary excretion of silicic acid (34.3 +/- 15.2 to 55.7 +/- 14.2 micromol/mmol creatinine) and concomitantly reduced significantly P=0.037) their urinary excretion of aluminium (86.0 +/- 24.3 to 62.2 +/- 23.2 nmol/mmol creatinine). The latter was achieved without any significant (P>0.05) influence upon the urinary excretion of iron (20.7 +/- 9.5 to 21.7 +/- 13.8 nmol/mmol creatinine). The reduction in urinary aluminium supported the future longer-term use of silicic acid as non-invasive therapy for reducing the body burden of aluminium in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of silicon on gastrointestinal absorption of aluminium
Edwardson, J. A., Moore, P. B., Ferrier, I. N., Lilley, J. S., Barker, J., Templar, J., & Day, J. P. (1993) · The Lancet · doi:10.1016/0140-6736(93)92301-9 · Cited by 143 · cited 1×
“Research during the past decade or so has shown that silicon, as its biologically available form silicic acid (Si(OH) 4 ), both reduces the gastrointestinal absorption of dietary Al [6] and facilitates the urinary excretion of systemic Al [15].”
Background
Cited by
Exley, C. (2013) · Environ. Sci.: Processes Impacts · doi:10.1039/c3em00374d · Cited by 382
Self-citationAluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link?
Tomljenovic, L. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101494 · Cited by 370
Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
Yegambaram, M., Manivannan, B., Beach, T., & Halden, R. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150204121719 · Cited by 273
Shaw, C. A., & Tomljenovic, L. (2013) · Immunologic Research · doi:10.1007/s12026-013-8403-1 · Cited by 269
Exley, C., & House, E. R. (2011) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-010-0417-y · Cited by 131
Self-citation
Metadata
- Authors
- Exley, C., Korchazhkina, O., Job, D., Strekopytov, S., Polwart, A., & Crome, P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2006-09-08
- Volume
- 10
- Issue
- 1
- Pages
- 17-24
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2170845239
- Cited by
- 61
- References
- 1
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease. https://app.cochat.ai/papers/10.3233/jad-2006-10103
- The paper
- Exley, C., Korchazhkina, O., Job, D., Strekopytov, S., Polwart, A., & Crome, P. (2006). Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-2006-10103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.